Extraction and identification of three major aldose reductase inhibitors from Artemisia montana

Food and Chemical Toxicology

Volumn 49, Issue 2, 2011, Pages 376-384

  Jung, Hyun Ah ^a   Islam, M D Nurul ^b   Kwon, Yong Soo ^c   Jin, Seong Eun ^b   Son, You Kyung ^b   Park, Jin Ju ^b   Sohn, Hee Sook ^a   Choi, Jae Sue ^b  

^a Chonbuk National University   (South Korea)

^b Pukyong National University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Aldose reductase; Artemisia montana; Caffeoylquinic acid; Compositae; HPLC; Hyperoside

Indexed keywords

3,5 DI O CAFFEOYLQUINIC ACID; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; APIGENIN; ARTEMISIA MONTANA EXTRACT; CHLOROGENIC ACID; CRYPTOCHLOROGENIC ACID; ESCULETIN; HYPERIN; ISOQUERCITRIN; LUTEOLIN; LUTEOLIN 7 RUTINOSIDE; NEOCHLOROGENIC ACID; PLANT EXTRACT; QUERCETIN; SCOPARONE; SCOPOLETIN; SCOPOLIN; UMBELLIFERONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTEMISIA; ARTEMISIA MONTANA; ARTICLE; COLUMN CHROMATOGRAPHY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; FRACTIONATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; LENS; NONHUMAN; PHYTOCHEMISTRY; RAT; SOLVENT EXTRACTION; SPECTROSCOPY;

ALDEHYDE REDUCTASE; ANIMALS; ARTEMISIA; FLAVONOIDS; INHIBITORY CONCENTRATION 50; LENS, CRYSTALLINE; MOLECULAR STRUCTURE; PLANT EXTRACTS; RATS; REPUBLIC OF KOREA;

ARTEMISIA; ASTERACEAE; RATTUS;

EID: 78951472562     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.11.012     Document Type: Article

References (58)

1. Bayoumi S.A., Rowan M.G., Beeching J.R., Blagbrough I.S. Constituents and secondary metabolite natural products in fresh and deteriorated cassava roots. Phytochemistry 2010, 71:598-604.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
3. Chung S.S., Ho E.C., Lam K.S., Chung S.K. Contribution of polyol pathway to diabetes-induced oxidative stress. J. Am. Soc. Nephrol. 2003, 14:S233-S236.
4. Costantino L., Rastelli G., Cignarella G., Vianello P., Barlocco D. New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complications. Exp. Opin. Ther. Patents 1997, 7:843-858.
5. Cui C.-B., Jeong S.K., Lee Y.S., Lee S.O., Kang I.-J., Lim S.S. Inhibitory activity of caffeoylquinic acids from the aerial parts of Artemisia princeps on rat lens aldose reductase and on the formation of advanced glycation end products. J. Korean Soc. Appl. Biol. Chem. 2009, 52:655-662.
6. de la Fuente J.A., Manzanaro S., Martín M.J., de Quesada T.G., Reymundo I., Luengo S.M., Gago F. Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product. J. Med. Chem. 2003, 46:5208-5221.
7. El-Kabbani O., Ruiz F., Darmanin C., Chung R.P.T. Aldose reductase structures: implications for mechanism and inhibition. Cell Mol. Life Sci. 2004, 61:750-762.
8. Halder N., Joshi S., Gupta S.K. Lens aldose reductase inhibiting potential of some indigenous plants. J. Ethnopharmacol. 2003, 86:113-116.
9. Hayat M.Q., Khan M.A., Ashraf M., Jabeen S. Ethnobotany of the genus Artemisia L. (Asteraceae) in Pakistan. Ethnobot. Res. Appl. 2009, 7:147-162.
10. Hayman S., Kinoshita J.H. Isolation and properties of lens aldose reductase. J. Biol. Chem. 1965, 240:877-882.
11. Jang D.S., Lee Y.M., Jeong I.H., Kim J.S. Constituents of the flowers of Platycodon grandiflorum with inhibitory activity on advanced glycation end products and rat lens aldose reductase in vitro. Arch. Pharm. Res. 2010, 33:875-880.
12. Jang D.S., Yoo N.H., Kim N.H., Lee Y.M., Kim C.S., Kim J., Kim J.H., Kim J.S. 3,5-Di-O-caffeoyl-epi-quinic acid from the leaves and stems of Erigeron annuus inhibits protein glycation, aldose reductase, and cataractogenesis. Biol. Pharm. Bull. 2010, 33:329-333.
13. Jang S.I., Kim Y.J., Lee W.Y., Kwak K.C., Baek S.H., Kwak G.B., Yun Y.G., Kwon T.O., Chung H.T., Chai K.Y. Scoparone from Artemisia capillaris inhibits the release of inflammatory mediators in RAW 264.7 cells upon stimulation cells by interferon-gamma Plus LPS. Arch. Pharm. Res. 2005, 28:203-208.
14. Jeong S.H., Han X.H., Hong S.S., Hwang J.S., Hwang J.H., Lee D., Lee M.K., Ro J.S., Hwang B.Y. Monoamine oxidase inhibitory coumarins from the aerial parts of Dictamnus albus. Arch. Pharm. Res. 2006, 29:1119-1124.
15. Jung H.A., Jung Y.J., Yoon N.Y., Jeong D.M., Bae H.J., Kim D.W., Na D.H., Choi J.S. Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress. Food Chem. Toxicol. 2008, 46:3818-3826.
16. Jung H.A., Kim A.R., Chung H.Y., Choi J.S. In vitro antioxidant activity of some selected Prunus species in Korea. Arch. Pharm. Res. 2002, 25:865-872.
17. Jung H.A., Kim Y.S., Choi J.S. Quantitative HPLC analysis of two key flavonoids and inhibitory activities against aldose reductase from different parts of the Korean thistle, Cirsium maackii. Food Chem. Toxicol. 2009, 47:2790-2797.
18. Kador P.F., Kinoshita J.H., Tung W.H., Chylack L.T. Differences in the susceptibility of various aldose reductases to inhibition. II. Invest. Ophthalmol. Vis. Sci. 1980, 19:980-982.
19. Kato A., Minoshima Y., Yamamoto J., Adachi I., Watson A.A., Nash R.J. Protective effects of dietary chamomile tea on diabetic complications. J. Agric. Food Chem. 2008, 56:8206-8211.
20. Kawanishi K., Ueda H., Moriyasu M. Aldose reductase inhibitors from the nature. Curr. Med. Chem. 2003, 10:1353-1374.
21. Kim J.S., Kwon C.S., Son K.H. Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci. Biotechnol. Biochem. 2000, 64:2458-2461.
22. Kim N.M., Kim J., Chung H.Y., Choi J.S. Isolation of luteolin 7-O-rutinoside and esculetin with potential antioxidant activity from the aerial parts of Artemisia montana. Arch. Pharm. Res. 2000, 23:237-239.
23. Kim S.H., Lee S.D., Kim W.B., Lee M.G., Kim N.D. Determination of a new antiulcer agent, eupatilin, in rat plasma, bile, urine, liver homogenate by high performance liquid chromatography. Res. Commun. Mol. Path. Pharmacol. 1997, 97:165-170.
24. Kim T.J. Korean Resources Plants 1996, Seoul National University Press, Korea, pp. 265.
25. Kimura Y., Okuda H., Okuda T., Hatano T., Agata I., Arichi S. Effects of extracts of leaves of Artemisia species, and caffeic acid and chlorogenic acid on lipid metabolic injury in rats fed peroxidized oil. Chem. Pharm. Bull. 1985, 33:2028-2034.
26. Kinoshita J.H. A thirty year journey in the polyol pathway. Exp. Eye. Res. 1990, 50:567-573.
27. Kordali S., Cakir A., Mavi A., Kilic H., Yildirim A. Screening of chemical composition and antifungal and antioxidant activities of the essential oils from three Turkish Artemisia species. J. Agric. Food Chem. 2005, 53:1408-1416.
28. Koreeda M., Nagaki M., Hayami K.I., Matsueda S. Studies on sesquiterpene lactones. XlII. Chemical constituent of Artemisia montana (Nakai) Pampan. Yakugaku Zasshi 1988, 108:434-436.
29. Kubo E., Miyoshi N., Fukuda M., Akagi Y. Cataract formation through the polyol pathway is associated with free radical production. Exp. Eye Res. 1999, 68:457-464.
30. Lee A.Y., Chung S.S. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999, 13:23-30.
31. Lee L.T., Huang Y.T., Hwang J.J., Lee P.P., Ke F.C., Nair M.P., Kanadaswami C., Lee M.T. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 2002, 22:1615-1627.
32. Lee S., Jung S.H., Lee Y.S., Yamada M., Kim B.K., Ohuchi K., Shin K.H. Antiinflammatory activity of hyperin from Acanthopanax chiisanensis roots. Arch. Pharm. Res. 2004, 27:628-632.
33. Lim S.S., Jung S.H., Ji J., Shin K.H., Keum S.R. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues. J. Pharm. Pharmacol. 2001, 53:653-668.
34. Logendra S., Ribnicky D., Yang H., Poulev A., Ma J., Kennelly E., Raskin I. Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus. Phytochemistry 2006, 67:1539-1546.
35. Matsuda H., Morikawa T., Toguchida I., Yoshikawa M. Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chem. Pharm. Bull. 2002, 50:788-795.
36. Matsueda S., Nagaki M. Studies on sesquiterpene lactones. XlI. Chemical constituent of Artemisia montana (Nakai). Yakugaku Zasshi 1984, 104:753-756.
37. Nagaki M., Matsueda S. Guaianolides from Artemisia montana. Phytochemistry 1989, 28:2731-2733.
38. Nakatani N., Kayano S., Kikuzaki H., Sumono K., Katagiri K., Mitani T. Identification, quantitative determination, and antioxidative activities of chlorogenic acid isomers in Prune (Prunus domestica L.). J. Agric. Food Chem. 2000, 48:5512-5516.
39. Nishimura C., Graham C., Hohman T.C., Nagata M., Robison W.G., Carper D. Characterization of mRNA and genes for aldose reductase in rat. Biochem. Biophys. Res. Commun. 1988, 153:1051-1059.
40. Nishimura C., Yamaoka T., Mizutani M., Yamashita K., Akera T., Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim. Biophys. Acta. 1991, 1078:171-178.
41. Okada Y., Miyauchi N., Suzuki K., Kobayashi T., Tsutsui C., Mayuzumi K., Nishibe S., Okuyama T. Search for naturally occurring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation. Chem. Pharm. Bull. 1995, 43:1385-1387.
42. Okuda T., Hatano T., Agata I., Nishibe S., Kimura K. Tannins in Artemisia montana, A. Princeps and related species of plant. Yakugaku Zasshi 1986, 106:894-899.
43. Rastelli G., Antolini L., Benvenuti S., Constantino L. Structural bases for the inhibition of aldose reductase by phenolic compounds. Bioorg. Med. Chem. 2000, 8:1151-1158.
44. Samejima K., Kanazawa K., Ashida H., Danno G. Luteolin: a strong antimutagen against dietary carcinogen, Trp-P-2, in peppermint, sage, and thyme. J. Agric. Food Chem. 1995, 43:410-414.
45. Sefi M., Fetoui H., Makni M., Zeghal N. Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advanced glycation end products and oxidative stress in alloxan-induced diabetic rats. Food Chem. Toxicol. 2010, 48:1986-1993.
46. Srivastava S.K., Ramana K.V., Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr. Rev. 2005, 26:380-392.
47. Tan R.X., Zheng W.F., Tang H.Q. Biologically active substances from the genus Artemisia. Planta Med. 1998, 64:295-302.
48. Tatefuji T., Izumi N., Ohta T., Arai S., Ikeda M., Kurimoto M. Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility. Biol. Pharm. Bull. 1996, 19:966-970.
49. Terashima S., Shimizu M., Horie S., Morita N. Studies on aldose reductase inhibitors from natural products. IV. Constituents and aldose reductase inhibitory effect of Chrysanthemum morifolium, Bixa orellana and Ipomoea batatas. Chem. Pharm. Bull. 1991, 39:3346-3347.
50. Ueda H., Yamazaki C., Yamazaki M. Luteolin as an anti-inflammatory and antiallergic constituent of Perilla frutescens. Biol. Pharm. Bull. 2002, 25:1197-1202.
51. Urzumtzev A., Tete-Favier F., Mitscier A., Barbanton J., Barth P., Urzhumgtseva L., Biellmann J.F., Podjarny A.D., Moras D. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure 1997, 5:601-612.
52. Valles, J., McArthur, E.D., 2001. Artemisia systematics and phylogeny: Cytogenetic and molecular insights, in: McArthur, E.D., Fairbanks, D.J. (Eds.), Shrubland Ecosystem Genetics and Biodiversity, Proceedings of June 13-15, 2000, Provo, Utah. US Department of Agriculture, Rocky Mountain Research Station, Ogden. pp. 67-74.
53. Wang Z., Ling B., Zhang R., Liu Y. Docking and molecular dynamics study on the inhibitory activity of coumarins on aldose reductase. J. Phys. Chem. B. 2008, 112:10033-10040.
54. Wawer I., Zielinska A. 13C CP/MAS NMR studies of flavonoids. Magn. Reson. Chem. 2001, 10:33-38.
55. Williamson J., Kilo C., Tilton R.G. Mechanisms of glucose and diabetes-induced vascular dysfunction. Hyperglycemia, Diabetes and Vascular Disease 1992, 691-714. Oxford University Press, New York. N. Ruderman, J.R. Williamson, M. Brownlee (Eds.).
56. Wright C.W. Artemisia. Medicinal and Aromatic Plants-Industrial Profiles 2005, Vol. 18. Taylor & Francis, New York, USA.
57. Yook C.S. Coloured Medicinal Plants in Korea 1989, Academic Publishing Co. Seoul, Korea, pp. 431-432.
58. Zargari A. Medicinal Plants, vol. 3 1996, Tehran University Press, Tehran, pp. 97-104. sixth ed.